Insufficient scRNA-seq data for expression of MYOZ3 at single-cell level.
Insufficient scRNA-seq data for expression of MYOZ3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 96% | 357.94 | 235 / 245 | 46% | 1.27 | 231 / 502 |
| brain | 79% | 278.66 | 2075 / 2642 | 34% | 0.89 | 240 / 705 |
| muscle | 100% | 6282.18 | 803 / 803 | 0% | 0 | 0 / 0 |
| uterus | 81% | 152.36 | 137 / 170 | 17% | 0.71 | 78 / 459 |
| heart | 95% | 397.47 | 816 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 90% | 281.98 | 1206 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 81% | 145.88 | 146 / 180 | 9% | 0.20 | 39 / 430 |
| breast | 53% | 101.77 | 242 / 459 | 31% | 1.05 | 352 / 1118 |
| lung | 71% | 114.98 | 411 / 578 | 9% | 0.18 | 109 / 1155 |
| thymus | 68% | 129.92 | 442 / 653 | 2% | 0.06 | 15 / 605 |
| bladder | 62% | 135.05 | 13 / 21 | 4% | 0.09 | 19 / 504 |
| kidney | 53% | 81.54 | 47 / 89 | 12% | 0.29 | 105 / 901 |
| pancreas | 7% | 9.19 | 24 / 328 | 46% | 0.99 | 81 / 178 |
| adipose | 45% | 63.89 | 545 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 28% | 38.85 | 102 / 359 | 11% | 0.22 | 31 / 286 |
| intestine | 29% | 36.57 | 281 / 966 | 6% | 0.11 | 29 / 527 |
| esophagus | 25% | 35.64 | 356 / 1445 | 4% | 0.07 | 7 / 183 |
| spleen | 25% | 25.00 | 60 / 241 | 0% | 0 | 0 / 0 |
| skin | 11% | 11.11 | 192 / 1809 | 14% | 0.29 | 67 / 472 |
| adrenal gland | 15% | 18.08 | 38 / 258 | 8% | 0.13 | 19 / 230 |
| eye | 0% | 0 | 0 / 0 | 19% | 0.29 | 15 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.52 | 4 / 45 |
| liver | 1% | 1.50 | 3 / 226 | 1% | 0.02 | 5 / 406 |
| peripheral blood | 2% | 4.14 | 14 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0030018 | Cellular component | Z disc |
| GO_0031433 | Molecular function | telethonin binding |
| GO_0051373 | Molecular function | FATZ binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003779 | Molecular function | actin binding |
| Gene name | MYOZ3 |
| Protein name | Myozenin 3 Myozenin-3 (Calsarcin-3) (FATZ-related protein 3) |
| Synonyms | FRP3 |
| Description | FUNCTION: Myozenins may serve as intracellular binding proteins involved in linking Z line proteins such as alpha-actinin, gamma-filamin, TCAP/telethonin, LDB3/ZASP and localizing calcineurin signaling to the sarcomere. Plays an important role in the modulation of calcineurin signaling. May play a role in myofibrillogenesis. |
| Accessions | ENST00000523553.1 ENST00000615557.1 [Q8TDC0-3] Q8TDC0 H0YC50 ENST00000297130.4 [Q8TDC0-1] ENST00000520112.1 E5RII7 ENST00000517768.6 [Q8TDC0-1] |